Attached files
Exhibit 23
Consent of L.E.K. Consulting LLC
L.E.K. Consulting LLC (L.E.K.) hereby consents to the use of L.E.K.s name and the statements attributed to L.E.K. in the periodic reports of Aegerion Pharmaceuticals, Inc. (the Company) filed with the Securities and Exchange Commission, and any amendments thereto (collectively, the Periodic Reports), provided that the statements attributed to L.E.K and the use of L.E.K.s name in the Periodic Reports are in the same form as the statements attributed to L.E.K. and the use of L.E.K.s name in the Companys Registration Statement on Form S-1 (Registration No: 333-1687214) dated September 17, 2010.
L.E.K. CONSULTING LLC |
/s/ Shuba Satyaprasad |
Shuba Satyaprasad, Esq. |
General Counsel |
December 1, 2010
Boston, MA
2